GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » FibroBiologics Inc (STU:SG0) » Definitions » Insider Ownership

FibroBiologics (STU:SG0) Insider Ownership : 0.00 % (As of Jun. 13, 2024)


View and export this data going back to 2024. Start your Free Trial

What is FibroBiologics Insider Ownership?

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, FibroBiologics's insider ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, FibroBiologics's Institutional Ownership is 0.11%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, FibroBiologics's Float Percentage Of Total Shares Outstanding is 0.00%.

FibroBiologics Insider Ownership Historical Data

The historical data trend for FibroBiologics's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

FibroBiologics Insider Ownership Chart

FibroBiologics Annual Data
Trend Dec21 Dec22 Dec23
Insider Ownership
- - -

FibroBiologics Quarterly Data
Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Insider Ownership Get a 7-Day Free Trial Premium Member Only - - - - -

FibroBiologics Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.

FibroBiologics (STU:SG0) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » FibroBiologics Inc (STU:SG0) » Definitions » Insider Ownership
Comparable Companies
Traded in Other Exchanges
FBLG:USA
Address
455 E. Medical Center Boulevard, Suite 300, Houston, TX, USA, 77598
Website
https://www.fibrobiologics.com
FibroBiologics Inc is an early-stage, cell therapy company. Its primary focus is the initiation and progression of preclinical studies and clinical-stage FDA trials related to fibroblast treatments for Degenerative Disc Disease, Multiple Sclerosis, Cancer, Wound Healing, and other diseases.

FibroBiologics (STU:SG0) Headlines

No Headlines